Plasma biomarkers for acute respiratory distress syndrome: A systematic review and Meta-Analysis*

Critical Care Medicine

Volumn 42, Issue 3, 2014, Pages 691-700

  Terpstra, Matty L ^a   Aman, Jurjan ^a   Van Nieuw Amerongen, Geerten P ^a   Groeneveld, A B Johan ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

acute lung injury; acute respiratory distress syndrome; diagnosis; mortality; plasma biomarker

Indexed keywords

ACUTE LUNG INJURY; ANGIOPOIETIN-2; BIOLOGICAL MARKERS; CRITICAL ILLNESS; FEMALE; HOSPITAL MORTALITY; HUMANS; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKINS; MALE; PROGNOSIS; PROTEIN C; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 84894493268     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/01.ccm.0000435669.60811.24     Document Type: Review

References (84)

1. Ashbaugh DG, Bigelow DB, Petty TL, et al: Acute respiratory distress in adults. Lancet 1967; 2:319-323
2. Tomashefski JF Jr: Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 2000; 21:435-466
3. Bernard GR, Artigas A, Brigham KL, et al: Report of the American- European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med 1994; 20:225-232
4. Villar J, Blanco J, Kacmarek RM: Acute respiratory distress syndrome definition: Do we need a change? Curr Opin Crit Care 2011; 17:13-17
5. Esteban A, Fernndez-Segoviano P, Frutos-Vivar F, et al: Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings. Ann Intern Med 2004; 141:440-445
6. Estenssoro E, Dubin A, Laffaire E, et al: Impact of positive end-expiratory pressure on the definition of acute respiratory distress syndrome. Intensive Care Med 2003; 29:1936-1942
7. Ranieri VM, Rubenfeld GD, Thompson BT, et al; ARDS Definition Task Force: Acute respiratory distress syndrome: The Berlin Definition. JAMA 2012; 307:2526-2533
8. Biomarkers Definitions Working Group: Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69:89-95
9. Barnett N, Ware LB: Biomarkers in acute lung injury-Marking forward progress. Crit Care Clin 2011; 27:661-683
10. Bhargava M, Wendt CH: Biomarkers in acute lung injury. Transl Res 2012; 159:205-217
11. Whiting P, Rutjes AW, Reitsma JB, et al: The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3:25
12. Stroup DF, Berlin JA, Morton SC, et al: Meta-Analysis of observational studies in epidemiology: A proposal for reporting. Meta-Analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-2012
13. Egger M, Davey Smith G, Schneider M, et al: Bias in meta-Analysis detected by a simple, graphical test. BMJ 1997; 315:629-634
14. Duval S, Tweedie R: Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-Analysis. Biometrics 2000; 56:455-463
15. Orwin RG. A failsafe N for effect size in meta-Analysis. J Educ Stat 1983; 8:157-159
16. Jochum M, Dwenger A, Joka T, et al: Posttraumatic plasma levels of mediators of organ failure. Prog Clin Biol Res 1989; 308:673-681
17. Determann RM, Royakkers AA, Haitsma JJ, et al: Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients. BMC Pulm Med 2010; 10:6
18. Determann RM, Millo JL, Waddy S, et al: Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilatorassociated pneumonia: A retrospective observational study. BMC Pulm Med 2009; 9:49
19. Nathani N, Perkins GD, Tunnicliffe W, et al: Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome. Crit Care 2008; 12:R12
20. Sato H, Callister ME, Mumby S, et al: KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome. Eur Respir J 2004; 23:142-145
21. Leff JA, Parsons PE, Day CE, et al: Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 1993; 341:777-780
22. Osaka D, Shibata Y, Kanouchi K, et al: Soluble endothelial selectin in acute lung injury complicated by severe pneumonia. Int J Med Sci 2011; 8:302-308
23. Moss M, Ackerson L, Gillespie MK, et al: von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151:15-20
24. Rubin DB, Wiener-Kronish JP, Murray JF, et al: Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990; 86:474-480
25. Fremont RD, Koyama T, Calfee CS, et al: Acute lung injury in patients with traumatic injuries: Utility of a panel of biomarkers for diagnosis and pathogenesis. J Trauma 2010; 68:1121-1127
26. van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, et al: Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ ARDS in septic and non-septic critically ill patients. Thorax 2008; 63:903-909
27. Siemiatkowski A, Kloczko J, Galar M, et al: von Willebrand factor antigen as a prognostic marker in posttraumatic acute lung injury. Haemostasis 2000; 30:189-195
28. Sakamaki F, Ishizaka A, Handa M, et al: Soluble form of P-selectin in plasma is elevated in acute lung injury. Am J Respir Crit Care Med 1995; 151:1821-1826
29. Donnelly SC, Haslett C, Dransfield I, et al: Role of selectins in development of adult respiratory distress syndrome. Lancet 1994; 344:215-219
30. Jabaudon M, Futier E, Roszyk L, et al: Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med 2011; 39:480-488
31. Uchida T, Shirasawa M, Ware LB, et al: Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006; 173:1008-1015
32. Lee YL, Chen W, Chen LY, et al: Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe communityacquired pneumonia. J Crit Care 2010; 25:176.e7-176.e13
33. Takala A, Jousela I, Takkunen O, et al: A prospective study of inflammation markers in patients at risk of indirect acute lung injury. Shock 2002; 17:252-257
34. Chollet-Martin S, Jourdain B, Gibert C, et al: Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Respir Crit Care Med 1996; 154:594-601
35. Endo S, Sato N, Nakae H, et al: Surfactant protein A and D (SP-A, AP-D) levels in patients with septic ARDS. Res Commun Mol Pathol Pharmacol 2002; 111:245-251
36. Bauer TT, Montn C, Torres A, et al: Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 2000; 55:46-52
37. Hensel M, Volk T, Dcke WD, et al: Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1998; 89:93-104
38. Roten R, Markert M, Feihl F, et al: Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome. Am Rev Respir Dis 1991; 143:590-592
39. Ware LB, Matthay MA, Parsons PE, et al; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network: Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007; 35:1821-1828
40. El Solh AA, Bhora M, Pineda L, et al: Alveolar plasminogen activator inhibitor-1 predicts ARDS in aspiration pneumonitis. Intensive Care Med 2006; 32:110-115
41. Kropski JA, Fremont RD, Calfee CS, et al: Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury. Chest 2009; 135:1440-1447
42. Calfee CS, Eisner MD, Parsons PE, et al; NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network: Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury. Intensive Care Med 2009; 35:248-257
43. Aman J, van der Heijden M, van Lingen A, et al: Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury/acute respiratory distress syndrome. Crit Care Med 2011; 39:89-97
44. Arif SK, Verheij J, Groeneveld AB, et al: Hypoproteinemia as a marker of acute respiratory distress syndrome in critically ill patients with pulmonary edema. Intensive Care Med 2002; 28:310-317
45. Ware LB, Fang X, Matthay MA: Protein C and thrombomodulin in human acute lung injury. Am J Physiol Lung Cell Mol Physiol 2003; 285:L514-L521
46. Headley AS, Tolley E, Meduri GU: Infections and the inflammatory response in acute respiratory distress syndrome. Chest 1997; 111:1306-1321
47. Meduri GU, Headley S, Kohler G, et al: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995; 107:1062-1073
48. Agouridakis P, Kyriakou D, Alexandrakis MG, et al: Association between increased levels of IL-2 and IL-15 and outcome in patients with early acute respiratory distress syndrome. Eur J Clin Invest 2002; 32:862-867
49. Nakashima T, Yokoyama A, Ohnishi H, et al: Circulating KL-6/MUC1 as an independent predictor for disseminated intravascular coagulation in acute respiratory distress syndrome. J Intern Med 2008; 263:432-439
50. Ishizaka A, Matsuda T, Albertine KH, et al: Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2004; 286:L1088-L1094
51. Nakamura T, Sato E, Fujiwara N, et al: Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome. Clin Biochem 2011; 44:601-604
52. Ganter MT, Cohen MJ, Brohi K, et al: Angiopoietin-2, marker and mediator of endothelial activation with prognostic significance early after trauma? Ann Surg 2008; 247:320-326
53. Gallagher DC, Parikh SM, Balonov K, et al: Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock 2008; 29:656-661
54. Lin MT, Wei YF, Ku SC, et al: Serum soluble triggering receptor expressed on myeloid cells-1 in acute respiratory distress syndrome: A prospective observational cohort study. J Formos Med Assoc 2010; 109:800-809
55. Chen CY, Yang KY, Chen MY, et al: Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndrome. Am J Respir Crit Care Med 2009; 180:751-760
56. Guervilly C, Lacroix R, Forel JM, et al: High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndrome. Crit Care 2011; 15:R31
57. Tseng JS, Chan MC, Hsu JY, et al: Procalcitonin is a valuable prognostic marker in ARDS caused by community-Acquired pneumonia. Respirology 2008; 13:505-509
58. Lesur O, Langevin S, Berthiaume Y, et al; Critical Care Research Group of the Qubec Respiratory Health Network: Outcome value of Clara cell protein in serum of patients with acute respiratory distress syndrome. Intensive Care Med 2006; 32:1167-1174
59. Bajwa EK, Khan UA, Januzzi JL, et al: Plasma C-reactive protein levels are associated with improved outcome in ARDS. Chest 2009; 136:471-480
60. Ware LB, Koyama T, Billheimer DD, et al; NHLBI ARDS Clinical Trials Network: Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010; 137:288-296
61. McClintock D, Zhuo H, Wickersham N, et al: Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit Care 2008; 12:R41
62. Parsons PE, Eisner MD, Thompson BT, et al; NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network: Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005; 33:1-6; discussion 230-232
63. Groeneveld AB, Raijmakers PG, Hack CE, et al: Interleukin 8-related neutrophil elastase and the severity of the adult respiratory distress syndrome. Cytokine 1995; 7:746-752
64. Ware LB, Eisner MD, Thompson BT, et al: Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 2004; 170:766-772
65. Ware LB, Conner ER, Matthay MA: von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med 2001; 29:2325-2331
66. Prabhakaran P, Ware LB, White KE, et al: Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol 2003; 285:L20-L28
67. Calfee CS, Ware LB, Eisner MD, et al; NHLBI ARDS Network: Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008; 63:1083-1089
68. Eisner MD, Parsons P, Matthay MA, et al; Acute Respiratory Distress Syndrome Network: Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003; 58:983-988
69. Cheng IW, Ware LB, Greene KE, et al: Prognostic value of surfactant proteins A and D in patients with acute lung injury. Crit Care Med 2003; 31:20-27
70. Matthay MA, Ware LB: Plasma protein C levels in patients with acute lung injury: Prognostic significance. Crit Care Med 2004; 32:S229-S232
71. Murray JF, Matthay MA, Luce JM, et al: An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723
72. Fowler AA, Hamman RF, Zerbe GO, et al: Adult respiratory distress syndrome. Prognosis after onset. Am Rev Respir Dis 1985; 132:472-478
73. Calfee CS, Ware LB, Glidden DV, et al; National Heart, Blood, and Lung Institute Acute Respiratory Distress Syndrome Network: Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med 2011; 39:711-717
74. Kohno N, Awaya Y, Oyama T, et al: KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993; 148:637-642
75. Fiedler U, Scharpfenecker M, Koidl S, et al: The Tie-2 ligand angiopoietin- 2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004; 103:4150-4156
76. Fijnheer R, Frijns CJ, Korteweg J, et al: The origin of P-selectin as a circulating plasma protein. Thromb Haemost 1997; 77:1081-1085
77. Agrawal A, Matthay MA, Kangelaris KN, et al: Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients. Am J Respir Crit Care Med 2013; 187:736-742
78. Davies HT, Crombie IK, Tavakoli M: When can odds ratios mislead? BMJ 1998; 316:989-991
79. Wygrecka M, Wilhelm J, Jablonska E, et al: Shedding of low-density lipoprotein receptor-related protein-1 in acute respiratory distress syndrome. Am J Respir Crit Care Med 2011; 184:438-448
80. Bersten AD, Hunt T, Nicholas TE, et al: Elevated plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute respiratory failure. Am J Respir Crit Care Med 2001; 164:648-652
81. Bajaj MS, Tricomi SM: Plasma levels of the three endothelial-specific proteins von Willebrand factor, tissue factor pathway inhibitor, and thrombomodulin do not predict the development of acute respiratory distress syndrome. Intensive Care Med 1999; 25:1259-1266
82. Amat M, Barcons M, Mancebo J, et al: Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: Mortality prognostic study. Crit Care Med 2000; 28:57-62
83. Schtte H, Lohmeyer J, Rosseau S, et al: Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 1996; 9:1858-1867
84. Stuck AE, Rubenstein LZ, Wieland D: Bias in meta-Analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ 1998; 316:469; author reply 470-471